Neuland Laboratories (NSE:NEULANDLAB) E10: ₹133.57 (As of Mar. 2026)


NSE:NEULANDLAB Neuland Laboratories Ltd NSE:NEULANDLAB
90 GF Score
Price ₹17,961.00
GF Value ₹16,469.67
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Neuland Laboratories E10?

Neuland Laboratories NSE:NEULANDLAB -0.61% 90 E10 is ₹133.57 as of Mar. 2026. GuruFocus rates NSE:NEULANDLAB with a GF Score™ of 90/100 and a GF Value™ of ₹16,469.67 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Neuland Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹165.760. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹133.57 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-26), Neuland Laboratories's current stock price is ₹17961.00. Neuland Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹133.57. Neuland Laboratories's Shiller PE Ratio of today is 134.47.

During the past 13 years, the highest Shiller PE Ratio of Neuland Laboratories was 155.56. The lowest was 93.20. And the median was 126.91.


Neuland Laboratories  (NSE:NEULANDLAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Neuland Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=17961.00/133.57
=134.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Neuland Laboratories was 155.56. The lowest was 93.20. And the median was 126.91.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Neuland Laboratories E10 Related Terms


Neuland Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Neuland Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuland Laboratories E10 Chart

Neuland Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 133.57

Neuland Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 114.43 115.50 133.57

NSE:NEULANDLAB vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuland Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Neuland Laboratories's Shiller PE Ratio falls into.


NSE:NEULANDLAB
90GF Score
Neuland Laboratories Ltd NSE:NEULANDLAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuland Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neuland Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=165.76/164.2724*164.2724
=165.760

Current CPI (Mar. 2026) = 164.2724.

Neuland Laboratories Quarterly Data

per share eps CPI Adj_EPS
201103 0.000 70.768 0.000
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 0.440 111.317 0.649
201809 3.550 115.142 5.065
201812 3.660 115.142 5.222
201903 5.220 118.202 7.255
201906 4.450 120.880 6.047
201909 6.770 123.175 9.029
201912 8.660 126.235 11.269
202003 -7.250 124.705 -9.550
202006 11.820 127.000 15.289
202009 16.710 130.118 21.096
202012 20.840 130.889 26.155
202103 13.480 131.771 16.805
202106 6.810 134.084 8.343
202109 15.880 135.847 19.203
202112 10.080 138.161 11.985
202203 16.970 138.822 20.081
202206 7.770 142.347 8.967
202209 29.970 144.661 34.033
202212 23.810 145.763 26.833
202303 65.900 146.865 73.711
202306 48.230 150.280 52.721
202309 69.560 151.492 75.428
202312 63.440 152.924 68.148
202403 52.660 153.035 56.527
202406 76.280 155.789 80.434
202409 25.600 157.882 26.636
202412 79.180 158.323 82.155
202503 21.670 157.552 22.594
202506 10.830 159.755 11.136
202509 75.490 162.289 76.412
202512 31.620 163.281 31.812
202603 165.760 164.272 165.760

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹133.57 mean?
Neuland Laboratories (NSE:NEULANDLAB) has a E10 of ₹133.57 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Neuland Laboratories and its competitors.
Is Neuland Laboratories' E10 too high?
Neuland Laboratories' current E10 is ₹133.57. Overall, Neuland Laboratories has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Neuland Laboratories' E10 compare to ZTS?
Neuland Laboratories' E10 of ₹133.57 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Neuland Laboratories and its competitors. Neuland Laboratories's current E10 is ₹133.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuland Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Neuland Laboratories (NSE:NEULANDLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹16,469.67, compared to a current price of ₹17,961.00 — trading 9.1% above its estimated fair value. The current E10 is ₹133.57. Neuland Laboratories' overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Neuland Laboratories (NSE:NEULANDLAB), the current E10 is ₹133.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuland Laboratories (NSE:NEULANDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Neuland Laboratories stock appears to be overvalued. The current stock price of ₹17,961.00 is trading 9.1% above its estimated GF Value™ of ₹16,469.67. GuruFocus considers Neuland Laboratories to be Fairly Valued.

Key valuation signals for NSE:NEULANDLAB:

  • E10: ₹133.57
  • GF Value™: ₹16,469.67 vs. price of ₹17,961.00 (9.1% above fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the NSE:NEULANDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neuland Laboratories Business Description

Other Exchanges 524558:India
Address Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033
Neuland Laboratories Ltd is engaged in the manufacturing and selling of bulk drugs and caters to both the domestic and international markets. It is an API contract development and manufacturing organization (CDMO), supporting biotechnology and pharmaceutical companies in the design, development, and manufacturing of complex active pharmaceutical ingredients (APIs). The company develops small molecules and peptides for clinical trials and beyond, with the capacity to scale up through every stage of the product lifecycle to commercial manufacturing. Geographically, the group derives maximum revenue from its customers in India, followed by Europe, the USA and North America, and the Rest of the world.
90GF Score

Get the complete analysis for NSE:NEULANDLAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹17,961.00
Price
₹16,469.67
GF Value